Aurinia Pharmaceuticals (AUPH) Enterprise Value (2016 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Enterprise Value of -$378.8 million for Q1 2026, up 4.83% on a QoQ basis from -$398.0 million in Q4 2025, and down 21.06% year-over-year from -$479.8 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Enterprise Value (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Enterprise Value history runs 11 years deep, the most recent figure standing at -$378.8 million for Q1 2026.
- Quarterly Enterprise Value fell 21.06% year-over-year to -$378.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$378.8 million (down 21.06% YoY) and the FY2025 annual result came in at -$398.0 million, down 11.02% from the prior year.
- Enterprise Value was -$378.8 million for Q1 2026 at Aurinia Pharmaceuticals, up from -$398.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$312.9 million in Q1 2025 and bottomed at -$418.7 million in Q1 2022.
- A 5-year average of -$358.3 million and a median of -$351.8 million in 2025 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 16.45% in 2022, while the deepest fall reached 31.51% in 2022.
- Aurinia Pharmaceuticals' Enterprise Value stood at -$389.4 million in 2022, then advanced by 9.99% to -$350.5 million in 2023, then decreased by 2.28% to -$358.5 million in 2024, then fell by 11.02% to -$398.0 million in 2025, then gained by 4.83% to -$378.8 million in 2026.
- Business Quant data shows AUPH's Enterprise Value at -$378.8 million in Q1 2026, -$398.0 million in Q4 2025, and -$351.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | -378.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -378.78 Mn |
| Dec 31, 2025 | -398.00 Mn |
| Sep 30, 2025 | -351.81 Mn |
| Jun 30, 2025 | -315.13 Mn |
| Mar 31, 2025 | -312.90 Mn |
| Dec 31, 2024 | -358.48 Mn |
| Sep 30, 2024 | -348.75 Mn |
| Jun 30, 2024 | -330.48 Mn |
| Mar 31, 2024 | -319.91 Mn |
| Dec 31, 2023 | -350.49 Mn |
| Sep 30, 2023 | -337.90 Mn |
| Jun 30, 2023 | -350.71 Mn |
| Mar 31, 2023 | -361.53 Mn |
| Dec 31, 2022 | -389.39 Mn |
| Sep 30, 2022 | -376.64 Mn |
| Jun 30, 2022 | -391.74 Mn |
| Mar 31, 2022 | -418.74 Mn |
| Dec 31, 2021 | -466.08 Mn |
| Sep 30, 2021 | -286.40 Mn |
| Jun 30, 2021 | -318.76 Mn |